New antibiotic safety study for kidney patients
Knowledge-focused
Recruiting now
This study is testing a new antibiotic called Cefiderocol/Xeruborbactam in 40 people with different levels of kidney function. The goal is to see how safe the drug is and how the body processes it. Participants receive a single dose, and researchers monitor side effects and drug …
Phase: PHASE1 • Sponsor: Qpex Biopharma, Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 11:35 UTC